PTGX icon

Protagonist Therapeutics
PTGX

Overview Fund Activity

240 hedge funds and large institutions have $2.44B invested in Protagonist Therapeutics in 2024 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 91 increasing their positions, 75 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
240
Holders Change
+1
Holders Change %
+0.42%
% of All Funds
3.2%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.09%
New
45
Increased
91
Reduced
75
Closed
41
Calls
$8.73M
Puts
$9.52M
Net Calls
-$795K
Net Calls Change
+$1.92M

Top Buyers

1
DTC
Deep Track Capital
Connecticut
$38.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
$36.3M
3
American Century Companies
American Century Companies
Missouri
$35.8M
4
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
$13.2M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
$11.4M

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
$0
2
BlackRock
BlackRock
New York
$382M
3
JFG
Jefferies Financial Group
New York
$57.5M
4
Marshall Wace
Marshall Wace
United Kingdom
$761K
5
CC
Checkpoint Capital
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GC
276
Globeflex Capital
California
– -$118K -2,627 Closed
QCG
277
Quadrant Capital Group
Ohio
– -$6.3K -140 Closed
TWD
278
True Wealth Design
Ohio
– -$4.32K -96 Closed
CPA
279
Capital Performance Advisors
California
– -$3.56K -79 Closed
S
280
SignatureFD
Georgia
– -$900 -20 Closed
MFG
281
Mendota Financial Group
Wisconsin
– -$270 -6 Closed
8 9 10 11
12